Literature DB >> 1913371

Dementia with leukoencephalopathy in systemic lupus erythematosus.

A Kirk1, A Kertesz, M J Polk.   

Abstract

Neurologic manifestations, afflicting up to 70% of SLE patients, include psychosis, seizures, chorea, neuropathies, and stroke. MRI is useful in evaluation of lupus patients and several reports have documented cerebral atrophy or focal hyperintensities. We report an unusual MRI appearance in a 56-year-old woman with SLE, diagnosed on the basis of pleuritis, lymphopenia, anti-DNA antibodies, and neurologic involvement. She reported recent onset of Raynaud's phenomenon and generalized macular rash. She presented after two months of gradual deterioration with memory loss, flattened affect, dysphagia, dysarthria, anomia, and somnolence, without focal neurologic signs. Investigations included elevated ESR, reduced complement, normal CSF without oligoclonal bands, negative viral serology, normal hormone and vitamin levels, normal renal and hepatic function. Neuropsychologic testing showed widespread impairment (WAIS-R: FSIQ-63; WMS-69; DRS-98; RCPM-14; WAB AQ-78.8). CT was normal but MRI showed strikingly symmetric, confluent hyperintensities extensively involving cerebral and cerebellar white matter on T1 and T2 weighted scans. Basal ganglia and subependymal and subcortical white matter were spared. Treated with prednisone, the patient made a gradual, but incomplete, recovery. These MRI findings may reflect widespread vasculopathy or direct immunologic brain insult with or without immunologic blood-brain barrier disruption.

Entities:  

Mesh:

Year:  1991        PMID: 1913371     DOI: 10.1017/s0317167100031929

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  8 in total

Review 1.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 2.  White matter: organization and functional relevance.

Authors:  Christopher M Filley
Journal:  Neuropsychol Rev       Date:  2010-03-31       Impact factor: 7.444

Review 3.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

4.  Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction.

Authors:  S I Lee; H S Jeon; W H Yoo
Journal:  Rheumatol Int       Date:  2004-02-28       Impact factor: 2.631

Review 5.  Vascular dementia: a review of recent evidence for prevention and treatment.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

6.  Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature.

Authors:  Alexandra Theisen; Paroma Bose; Christina Knight; Melissa Oliver
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-13       Impact factor: 3.054

7.  Case Report: Rapid Progression of Cognitive Dysfunction as an Initial Feature of Systemic Lupus Erythematosus With Leukoencephalopathy: A Case Report and Literature Review.

Authors:  Yukun Feng; Teng Yu; Qin Xiao; Xiaodong Yang
Journal:  Front Neurol       Date:  2022-07-11       Impact factor: 4.086

Review 8.  What matters in white matter dementia?

Authors:  Leonardo Caixeta
Journal:  Dement Neuropsychol       Date:  2007 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.